Investment Analysts’ Recent Ratings Updates for Ryan Specialty (RYAN)

Ryan Specialty (NYSE: RYAN) recently received a number of ratings updates from brokerages and research firms:

• 5/4/2026 – Ryan Specialty had its price target lowered by Citigroup Inc. from $55.00 to $50.00. They now have a “buy” rating on the stock.
• 5/4/2026 – Ryan Specialty had its price target lowered by UBS Group AG from $59.00 to $51.00. They now have a “buy” rating on the stock.
• 5/1/2026 – Ryan Specialty had its “buy” rating reaffirmed by The Goldman Sachs Group, Inc.. They now have a $42.00 price target on the stock.
• 5/1/2026 – Ryan Specialty was given a new $35.00 price target by Mizuho.
• 5/1/2026 – Ryan Specialty was given a new $35.00 price target by UBS Group AG.
• 5/1/2026 – Ryan Specialty had its price target lowered by Barclays PLC from $41.00 to $39.00. They now have an “overweight” rating on the stock.
• 5/1/2026 – Ryan Specialty had its price target lowered by Piper Sandler from $43.00 to $35.00. They now have a “neutral” rating on the stock.
• 5/1/2026 – Ryan Specialty had its price target lowered by Keefe, Bruyette & Woods from $49.00 to $42.00. They now have an “outperform” rating on the stock.
• 5/1/2026 – Ryan Specialty was downgraded by Wells Fargo & Company from “overweight” to “equal weight”. They now have a $31.00 price target on the stock, down from $42.00.
• 4/14/2026 – Ryan Specialty had its price target lowered by Bank of America Corporation from $70.00 to $68.00. They now have a “buy” rating on the stock.
• 4/13/2026 – Ryan Specialty had its price target lowered by Mizuho from $44.00 to $42.00. They now have a “neutral” rating on the stock.
• 4/9/2026 – Ryan Specialty had its price target lowered by JPMorgan Chase & Co. from $49.00 to $43.00. They now have an “underweight” rating on the stock.
• 4/9/2026 – Ryan Specialty had its price target lowered by Wells Fargo & Company from $56.00 to $42.00. They now have an “overweight” rating on the stock.
• 4/9/2026 – Ryan Specialty had its price target lowered by Cantor Fitzgerald from $45.00 to $40.00. They now have a “neutral” rating on the stock.
• 4/8/2026 – Ryan Specialty had its price target lowered by UBS Group AG from $65.00 to $59.00. They now have a “buy” rating on the stock.
• 4/8/2026 – Ryan Specialty had its price target lowered by Barclays PLC from $45.00 to $41.00. They now have an “overweight” rating on the stock.
• 4/8/2026 – Ryan Specialty had its price target lowered by The Goldman Sachs Group, Inc. from $57.00 to $49.00. They now have a “buy” rating on the stock.
• 4/7/2026 – Ryan Specialty had its price target lowered by Keefe, Bruyette & Woods from $55.00 to $49.00. They now have an “outperform” rating on the stock.
• 4/6/2026 – Ryan Specialty had its price target lowered by Morgan Stanley from $55.00 to $50.00. They now have an “overweight” rating on the stock.
• 3/23/2026 – Ryan Specialty had its price target lowered by Citigroup Inc. from $60.00 to $55.00. They now have a “buy” rating on the stock.
• 3/17/2026 – Ryan Specialty is now covered by Royal Bank Of Canada. They set an “outperform” rating and a $45.00 price target on the stock.
• 3/11/2026 – Ryan Specialty had its price target lowered by Barclays PLC from $52.00 to $45.00. They now have an “overweight” rating on the stock.

Ryan Specialty Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 26th. Shareholders of record on Tuesday, May 12th will be issued a dividend of $0.13 per share. This represents a $0.52 annualized dividend and a yield of 1.8%. The ex-dividend date is Tuesday, May 12th. Ryan Specialty’s dividend payout ratio (DPR) is presently 67.53%.

Insider Buying and Selling

In other news, Director Patrick G. Ryan, Jr. acquired 25,500 shares of Ryan Specialty stock in a transaction on Monday, February 23rd. The shares were bought at an average cost of $39.96 per share, for a total transaction of $1,018,980.00. Following the acquisition, the director directly owned 428,295 shares of the company’s stock, valued at $17,114,668.20. This trade represents a 6.33% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. 52.03% of the stock is owned by insiders.

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.